Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Quantum Biopharma (QNTM) EPS (Basic) (2019 - 2025)

Quantum Biopharma's EPS (Basic) history spans 7 years, with the latest figure at -$0.0 for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 100.0% to -$0.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $8.01, a 1016.55% increase, with the full-year FY2025 number at -$0.44, changed N/A from a year prior.
  • EPS (Basic) hit -$0.0 in Q4 2025 for Quantum Biopharma, down from $1.25 in the prior quarter.
  • Over the last five years, EPS (Basic) for QNTM hit a ceiling of $3.53 in Q1 2025 and a floor of -$4.37 in Q3 2024.
  • Historically, EPS (Basic) has averaged $0.35 across 5 years, with a median of -$0.02 in 2023.
  • Biggest five-year swings in EPS (Basic): tumbled 14466.67% in 2024 and later surged 3937.5% in 2025.
  • Tracing QNTM's EPS (Basic) over 5 years: stood at -$0.15 in 2021, then dropped by 26.67% to -$0.19 in 2022, then skyrocketed by 72.54% to -$0.05 in 2023, then soared by 73.31% to -$0.01 in 2024, then surged by 100.0% to -$0.0 in 2025.
  • Business Quant data shows EPS (Basic) for QNTM at -$0.0 in Q4 2025, $1.25 in Q3 2025, and $3.23 in Q2 2025.